GO:2000110 negative regulation of macrophage apoptotic process: Cell Death Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000110 describes any process that stops, prevents, or reduces the frequency, rate or extent of macrophage apoptotic process, a key checkpoint in innate immunity and tissue homeostasis.
• Macrophage survival is actively maintained by anti-apoptotic programs such as ATF3-dependent transcriptional control, which coordinates cardiac macrophage survival and proliferation and protects against ischemia-reperfusion injury.
• Efferocytosis of apoptotic cells reprograms macrophage metabolism and epigenetics, including methionine salvage and DNMT3A activity, to promote tissue resolution.
• Dysregulated macrophage apoptosis or pyroptosis contributes to severe acute pancreatitis lung injury, CoCrMo particle-induced osteolysis, Pseudomonas aeruginosa pneumonia, and diabetic periodontitis [1,5,7,8].
• ESCRT-dependent membrane repair acts as a cell-intrinsic brake on GSDMD-driven pyroptosis, illustrating how negative regulation of macrophage death is mechanistically coupled to membrane integrity.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of genes that negatively regulate macrophage apoptosis in disease contexts.
Description
Macrophages are central effectors of innate immunity, tissue remodeling, and resolution of inflammation, and their lifespan is tightly controlled by the balance between pro-death and pro-survival signals [2,4]. The Gene Ontology term GO:2000110, negative regulation of macrophage apoptotic process, captures the biological processes that stop, prevent, or reduce the frequency, rate or extent of macrophage apoptosis. This term is distinct from general apoptosis regulation because it is cell-type specific and is frequently studied in the context of inflammatory and infectious disease models [1,7]. Understanding this term is important because macrophage persistence versus death determines the outcome of injury, infection, and chronic inflammation [4,7]. For example, ATF3 coordinates the survival and proliferation of cardiac macrophages and protects against ischemia-reperfusion injury, directly linking negative regulation of macrophage apoptosis to organ protection. Conversely, failure to restrain macrophage death, or a shift toward pyroptosis, aggravates lung injury during severe acute pancreatitis through mtDNA-cGAS-STING-IRF7/IRF3 signaling. Efferocytosis of apoptotic cells also reprograms macrophages metabolically and epigenetically, using apoptotic cell-derived methionine and DNMT3A to promote tissue resolution. Thus, GO:2000110 is not merely a cell-death annotation but a hub connecting immunometabolism, epigenetic regulation, and tissue repair [2,4].
negative regulation of macrophage apoptotic process At A Glance
| GO ID | GO:2000110 |
|---|---|
| GO term | negative regulation of macrophage apoptotic process |
| Ontology | biological_process |
| Synonym | negative regulation of activation-induced cell death; negative regulation of AICD; negative regulation of macrophage apoptosis |
| Major function | Stops, prevents, or reduces the frequency, rate or extent of macrophage apoptotic process |
| Cell type | Macrophages, including tissue-resident and monocyte-derived macrophages |
| Related processes | Efferocytosis, immunometabolism, epigenetic regulation, membrane repair, cytokine signaling |
| Disease relevance | Ischemia-reperfusion injury, severe acute pancreatitis lung injury, particle-induced osteolysis, bacterial pneumonia, diabetic periodontitis |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, flow cytometry, RNA-seq, proteomics, imaging |
What Is GO:2000110?
GO:2000110, negative regulation of macrophage apoptotic process, is defined as any process that stops, prevents, or reduces the frequency, rate or extent of macrophage apoptotic process. In practical terms, it includes signaling, transcriptional, metabolic, and membrane-repair mechanisms that keep macrophages alive under conditions that would otherwise trigger apoptosis. It is a biological_process term and is synonymous with negative regulation of activation-induced cell death (AICD) and negative regulation of macrophage apoptosis. This term is narrower than generic negative regulation of apoptotic process because it applies specifically to macrophages, a cell type whose survival decisions shape innate immune responses and tissue homeostasis [2,4].
Why Is negative regulation of macrophage apoptotic process Important in Cell Biology?
Negative regulation of macrophage apoptotic process is important because macrophage survival directly determines the magnitude and duration of innate immune responses and the efficiency of tissue repair [2,4]. When this regulation fails, macrophages die prematurely or undergo pyroptosis, releasing inflammatory contents that amplify tissue damage, as seen in severe acute pancreatitis-associated lung injury. Conversely, excessive macrophage survival can perpetuate inflammation, making this process a therapeutic target in both acute injury and chronic inflammatory disease [4,7]. The term also intersects with efferocytosis, where macrophages that survive and clear apoptotic cells acquire a resolution phenotype dependent on methionine metabolism and DNMT3A. Therefore, GO:2000110 provides a mechanistic framework for understanding how macrophages balance death and survival in health and disease [2,4,7].
• Controls macrophage lifespan, which shapes the intensity and resolution of innate immune responses [2,4].
• Protects organs from ischemia-reperfusion injury through ATF3-dependent cardiac macrophage survival.
• Limits pyroptotic macrophage death that aggravates lung injury in severe acute pancreatitis.
• Supports efferocytosis and tissue resolution via apoptotic cell-derived methionine and DNMT3A.
• Modulates osteoclastogenesis and particle-induced inflammation in orthopedic implant models.
• Influences outcomes in bacterial pneumonia through SIRT1-dependent regulation of macrophage pyroptosis.
• Is relevant to diabetic periodontitis bone healing via ANXA1/NLRP3/Caspase-1/GSDMD signaling.
• Provides a mechanistic target for TRIM28/miR133a/CD47-dependent efferocytosis in pancreatic necrosis.
• Couples membrane repair machinery (ESCRT) to suppression of GSDMD-driven macrophage death.
• Offers CRISPR-tractable nodes for therapeutic modulation of macrophage persistence in disease [4,7].
What Happens During negative regulation of macrophage apoptotic process?
Survival signaling and transcriptional control
In simple terms: Macrophages receive signals that tell them to stay alive rather than self-destruct.
Negative regulation of macrophage apoptosis begins with survival signaling that converges on transcriptional programs maintaining mitochondrial integrity and anti-apoptotic gene expression. ATF3 coordinates the survival and proliferation of cardiac macrophages and protects against ischemia-reperfusion injury, demonstrating that a single transcription factor can orchestrate a macrophage survival program in vivo. This transcriptional layer integrates stress and inflammatory cues to prevent inappropriate macrophage apoptosis during tissue stress.
Metabolic and epigenetic reprogramming during efferocytosis
In simple terms: When macrophages eat dying cells, their metabolism and DNA marks change to keep them alive and promote healing.
Efferocytosis of apoptotic cells reprograms macrophage metabolism and epigenetics to promote tissue resolution. Macrophages use apoptotic cell-derived methionine and DNMT3A during efferocytosis to promote tissue resolution, linking nutrient salvage to epigenetic maintenance of the resolving macrophage phenotype. This metabolic-epigenetic axis supports macrophage survival and function after clearance of apoptotic cells, reinforcing the negative regulation of macrophage apoptotic process.
Membrane repair and suppression of pyroptosis
In simple terms: Cells patch holes in their membrane to avoid a lytic, inflammatory form of death.
ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation, providing a cell-intrinsic mechanism that restrains lytic macrophage death after inflammasome activation. Because pyroptosis and apoptosis are distinct but interconnected death modalities, membrane repair acts as a brake that preserves macrophage viability under inflammatory stress. This mechanism is particularly relevant when GSDMD is activated by danger signals such as mtDNA-cGAS-STING signaling.
Inflammasome and cytokine-dependent modulation
In simple terms: Inflammatory sensors and cytokines can either push macrophages to die or help them survive.
Inflammasome and cytokine signaling modulate macrophage survival in a context-dependent manner. Propionate and butyrate attenuate macrophage pyroptosis and osteoclastogenesis induced by CoCrMo alloy particles, indicating that microbial metabolites can negatively regulate macrophage death in particle-induced inflammation. Similarly, SIRT1 regulates macrophage pyroptosis during Pseudomonas aeruginosa-induced pneumonia, showing that sirtuin activity influences macrophage death pathways in bacterial infection. Ac2-26/OGP-loaded hydrogel ameliorates macrophage pyroptosis via the ANXA1/NLRP3/Caspase-1/GSDMD pathway to enhance bone healing in diabetic periodontitis, further illustrating therapeutic modulation of macrophage death.
Efferocytosis receptor and microRNA control
In simple terms: Receptors and small RNAs control how well macrophages clear dying cells and avoid death themselves.
The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosis, linking microRNA and ubiquitin-like machinery to macrophage clearance function and survival. Impaired efferocytosis can shift macrophages toward death and necrosis, whereas efficient efferocytosis supports the negative regulation of macrophage apoptotic process and tissue resolution [2,3]. Together, these pathways define a multilayered system that keeps macrophages alive and functional during inflammation and repair [2,3,4].
Key Genes Involved in GO:2000110 negative regulation of macrophage apoptotic process
The following genes and proteins have been experimentally implicated in the negative regulation of macrophage apoptotic process or in closely related macrophage death and survival pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATF3 | Transcription factor coordinating cardiac macrophage survival and proliferation | Protects against ischemia-reperfusion injury; KO models test macrophage survival in heart injury |
| DNMT3A | DNA methyltransferase using apoptotic cell-derived methionine during efferocytosis | Epigenetic maintenance of resolving macrophage phenotype; KO/point-mutation models test efferocytosis |
| TRIM28 | Scaffold protein in TRIM28/miR133a/CD47 axis | Impairs efferocytosis in pancreatic necrosis; candidate therapeutic target |
| CD47 | Efferocytosis-related surface protein regulated by miR133a | Modulates clearance of dying cells; knock-in/overexpression models test efferocytosis |
| SIRT1 | NAD-dependent deacetylase regulating macrophage pyroptosis | Modulates macrophage death in Pseudomonas aeruginosa pneumonia |
| ANXA1 | Annexin A1, upstream of NLRP3/Caspase-1/GSDMD | Ac2-26/OGP hydrogel ameliorates macrophage pyroptosis in diabetic periodontitis |
| NLRP3 | Inflammasome sensor driving pyroptosis | Central node in macrophage lytic death; KO models test inflammasome-dependent death |
| Caspase-1 | Inflammatory caspase activating GSDMD | Effector of pyroptosis; point-mutation models test catalytic function |
| GSDMD | Gasdermin D pore-forming executioner of pyroptosis | Target of ESCRT-dependent membrane repair; KO models test lytic death |
| cGAS | Cytosolic DNA sensor in mtDNA-cGAS-STING axis | Promotes macrophage pyroptosis in severe acute pancreatitis lung injury |
| STING | Adaptor in cGAS-STING innate immune signaling | Links mtDNA sensing to IRF7/IRF3 activation and macrophage death |
| IRF7 | Interferon regulatory factor downstream of STING | Contributes to macrophage pyroptosis in lung injury |
| IRF3 | Interferon regulatory factor downstream of STING | Contributes to macrophage pyroptosis in lung injury |
| ESCRT components | Membrane repair machinery | Negatively regulates pyroptosis downstream of GSDMD activation |
| miR133a | MicroRNA targeting CD47 in TRIM28 axis | Modulates efferocytosis in pancreatic necrosis |
| Methionine salvage enzymes | Recycle apoptotic cell-derived methionine | Support DNMT3A-dependent resolving macrophage phenotype |
How Is negative regulation of macrophage apoptotic process Regulated?
Negative regulation of macrophage apoptotic process is controlled at multiple levels. Transcriptionally, ATF3 coordinates survival and proliferation of cardiac macrophages, integrating stress signals into a protective program. Metabolically and epigenetically, apoptotic cell-derived methionine and DNMT3A sustain the resolving macrophage phenotype during efferocytosis. At the membrane, ESCRT-dependent repair negatively regulates pyroptosis downstream of GSDMD activation, preventing lytic death after inflammasome triggering. Inflammatory and microbial cues further tune this balance: propionate and butyrate attenuate macrophage pyroptosis and osteoclastogenesis induced by CoCrMo particles, SIRT1 regulates macrophage pyroptosis during Pseudomonas aeruginosa pneumonia, and ANXA1/NLRP3/Caspase-1/GSDMD signaling can be targeted to ameliorate macrophage pyroptosis in diabetic periodontitis. Finally, the TRIM28/miR133a/CD47 axis modulates efferocytosis and macrophage fate in pancreatic necrosis. Together, these layers form a regulatory network that determines whether macrophages survive, resolve inflammation, or die.
negative regulation of macrophage apoptotic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| cGAS/STING/IRF7/IRF3 | Severe acute pancreatitis-associated lung injury | Macrophage KO of cGAS or STING; pyroptosis assays |
| ATF3 | Cardiac ischemia-reperfusion injury | Cardiac macrophage-specific ATF3 KO and overexpression |
| TRIM28/miR133a/CD47 | Pancreatic necrosis and impaired efferocytosis | miR133a mimic/inhibitor; CD47 knock-in reporter |
| SIRT1 | Pseudomonas aeruginosa pneumonia | SIRT1 KO macrophages; bacterial infection models |
| ANXA1/NLRP3/Caspase-1/GSDMD | Diabetic periodontitis bone healing | GSDMD KO and Caspase-1 point-mutation macrophages |
Severe acute pancreatitis and lung injury
Mitochondrial DNA-cGAS-STING signaling promotes pyroptosis of macrophages via IRF7/IRF3 activation to aggravate lung injury during severe acute pancreatitis. This illustrates how failure to negatively regulate macrophage death amplifies organ damage and identifies cGAS-STING-IRF7/IRF3 as candidate targets for preserving macrophage viability.
Ischemia-reperfusion injury and cardiac protection
ATF3 coordinates the survival and proliferation of cardiac macrophages and protects against ischemia-reperfusion injury, directly linking negative regulation of macrophage apoptosis to cardioprotection. Modulating ATF3-dependent survival programs may therefore limit myocardial damage after ischemic events.
Pancreatic necrosis and impaired efferocytosis
The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosis, connecting defective clearance of dying cells to macrophage fate and tissue necrosis. Restoring efficient efferocytosis may support the negative regulation of macrophage apoptotic process and limit necrosis [2,3].
Bacterial pneumonia and particle-induced inflammation
SIRT1 regulates macrophage pyroptosis during Pseudomonas aeruginosa-induced pneumonia, and propionate/butyrate attenuate macrophage pyroptosis and osteoclastogenesis induced by CoCrMo alloy particles [5,7]. These findings show that macrophage death regulation is relevant to both infectious and implant-related inflammatory disease [5,7]. In diabetic periodontitis, Ac2-26/OGP-loaded hydrogel ameliorates macrophage pyroptosis via ANXA1/NLRP3/Caspase-1/GSDMD to enhance bone healing.
From negative regulation of macrophage apoptotic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene causally prevent macrophage apoptosis? | CRISPR knockout in macrophage cell lines or primary macrophages |
| Does a specific catalytic residue control macrophage survival? | CRISPR point mutation of the catalytic site |
| Does a disease-associated variant alter macrophage death? | CRISPR knock-in of the variant allele |
| Where and when is the protein expressed during efferocytosis? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of an anti-apoptotic gene protect macrophages? | CRISPR overexpression or lentiviral overexpression |
| Which genes regulate macrophage pyroptosis at genome scale? | CRISPR library screening with pyroptosis readout |
How to Study the negative regulation of macrophage apoptotic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry (Annexin V/PI) | Apoptotic and lytic macrophage death | Quantify negative regulation of macrophage apoptosis [6,8] |
| RNA-seq | Transcriptional survival programs | ATF3-dependent cardiac macrophage survival |
| DNA methylation profiling | Epigenetic changes during efferocytosis | DNMT3A-dependent resolving phenotype |
| Proteomics | Protein complexes and cleavage events | ESCRT-dependent membrane repair and GSDMD processing |
| Live-cell imaging | Membrane repair and pore formation | Pyroptosis suppression downstream of GSDMD |
| Efferocytosis assays | Clearance of apoptotic cells | TRIM28/miR133a/CD47 axis in pancreatic necrosis |
| CRISPR library screening | Genome-wide regulators of macrophage death | Identify negative regulators of pyroptosis |
| Cytokine profiling | Inflammatory output of surviving macrophages | Lung injury and pneumonia models [1,7] |
Flow cytometry and viability assays
Flow cytometry with Annexin V/propidium iodide or caspase activity dyes quantifies macrophage apoptosis and distinguishes it from pyroptosis, which is essential for studying GO:2000110 [6,8]. These assays are typically applied to macrophages treated with inflammatory stimuli or efferocytosis targets [2,8].
Transcriptomics and epigenomics
RNA-seq and DNA methylation profiling reveal transcriptional and epigenetic programs underlying macrophage survival, including DNMT3A-dependent methylation changes during efferocytosis. ATF3-dependent transcriptional networks can be mapped by RNA-seq in cardiac macrophages.
Proteomics and interactomics
Proteomics identifies ESCRT components and GSDMD processing events that control membrane repair and pyroptosis. Interactomics can define complexes such as TRIM28/miR133a/CD47 regulatory modules.
Imaging and functional assays
Live-cell imaging of membrane repair, GSDMD pore formation, and efferocytosis provides spatial and temporal resolution of macrophage death regulation [2,6]. These methods are applied in disease models such as lung injury, pancreatic necrosis, and periodontitis [1,3,8].
How CRISPR Can Be Used to Study GO:2000110 negative regulation of macrophage apoptotic process
Knockout
CRISPR knockout of candidate genes such as ATF3, SIRT1, or GSDMD in macrophages tests whether they are required for negative regulation of macrophage apoptotic process [4,6,7]. KO models are typically validated by flow cytometry and disease challenge experiments [4,7].
Point Mutation
CRISPR point mutation of catalytic residues in Caspase-1 or GSDMD distinguishes enzymatic function from scaffolding roles in macrophage death [6,8]. Such models are useful when complete knockout causes confounding developmental or inflammatory phenotypes.
Knock-in
CRISPR knock-in of disease-associated variants or fluorescent tags enables allele-specific analysis of macrophage survival genes such as CD47 or DNMT3A [2,3]. Tagged knock-in allows tracking of protein localization during efferocytosis and membrane repair [2,6].
Overexpression
CRISPR overexpression or lentiviral overexpression of anti-apoptotic genes such as ATF3 tests sufficiency for protecting macrophages from apoptosis. Overexpression models complement KO studies to establish causality in GO:2000110 research [4,7].
How EDITGENE Supports negative regulation of macrophage apoptotic process Research
Researchers studying negative regulation of macrophage apoptotic process-related genes often need to determine whether a candidate gene is causally involved in macrophage survival, pyroptosis, or efferocytosis. EDITGENE provides CRISPR-based cell model generation and screening services to support such causal studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of macrophage apoptotic process research.
Frequently Asked Questions About negative regulation of macrophage apoptotic process
What is GO:2000110 negative regulation of macrophage apoptotic process?
GO:2000110 is a Gene Ontology biological_process term defined as any process that stops, prevents, or reduces the frequency, rate or extent of macrophage apoptotic process.
What genes are involved in negative regulation of macrophage apoptotic process?
Genes experimentally implicated include ATF3, DNMT3A, TRIM28, CD47, SIRT1, ANXA1, NLRP3, Caspase-1, GSDMD, cGAS, STING, IRF7, and IRF3 [1,2,3,4,6,7,8].
How is macrophage apoptosis negatively regulated during efferocytosis?
Efferocytosis reprograms macrophages to use apoptotic cell-derived methionine and DNMT3A, promoting tissue resolution and supporting macrophage survival.
What is the role of ATF3 in macrophage survival?
ATF3 coordinates the survival and proliferation of cardiac macrophages and protects against ischemia-reperfusion injury.
How does ESCRT-dependent membrane repair affect macrophage death?
ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation, preventing lytic macrophage death.
Is negative regulation of macrophage apoptosis relevant to lung injury?
Yes, mtDNA-cGAS-STING signaling promotes macrophage pyroptosis via IRF7/IRF3 activation to aggravate lung injury during severe acute pancreatitis.
Can microbial metabolites modulate macrophage pyroptosis?
Propionate and butyrate attenuate macrophage pyroptosis and osteoclastogenesis induced by CoCrMo alloy particles.
What role does SIRT1 play in macrophage pyroptosis?
SIRT1 regulates macrophage pyroptosis during Pseudomonas aeruginosa-induced pneumonia.
How can CRISPR be used to study negative regulation of macrophage apoptotic process?
CRISPR knockout, point mutation, knock-in, and overexpression models test causal roles of genes such as ATF3, GSDMD, and Caspase-1 in macrophage survival [4,6,8].
What diseases are linked to defective negative regulation of macrophage apoptosis?
Severe acute pancreatitis lung injury, ischemia-reperfusion injury, pancreatic necrosis, bacterial pneumonia, particle-induced osteolysis, and diabetic periodontitis [1,3,4,5,7,8].
Conclusion
GO:2000110 negative regulation of macrophage apoptotic process is a biologically_process term that defines the active mechanisms keeping macrophages alive under inflammatory and metabolic stress. Experimental evidence links this process to ATF3-dependent cardiac macrophage survival, DNMT3A-dependent epigenetic reprogramming during efferocytosis, ESCRT-dependent membrane repair, and inflammasome-modulating pathways [2,4,6,8]. Dysregulation of these mechanisms contributes to lung injury, ischemia-reperfusion injury, pancreatic necrosis, pneumonia, and periodontitis, making them attractive therapeutic targets [1,3,4,7,8]. CRISPR-based knockout, point-mutation, knock-in, overexpression, and library screening approaches provide the causal toolkit needed to dissect and therapeutically exploit this process [4,6,8].
References
- 1. Peng Y et al.. 2024. Mitochondrial (mt)DNA-cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling promotes pyroptosis of macrophages via interferon regulatory factor (IRF)7/IRF3 activation to aggravate lung injury during severe acute pancreatitis.. Cell Mol Biol Lett 29(1):61 PMID: 38671352
- 2. Ampomah PB et al.. 2022. Macrophages use apoptotic cell-derived methionine and DNMT3A during efferocytosis to promote tissue resolution.. Nat Metab 4(4):444-457 PMID: 35361955
- 3. Zhu Q et al.. 2024. The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosis.. Mol Ther 32(9):3025-3041 PMID: 38872307
- 4. Shao Y et al.. 2024. ATF3 coordinates the survival and proliferation of cardiac macrophages and protects against ischemia-reperfusion injury.. Nat Cardiovasc Res 3(1):28-45 PMID: 39195894
- 5. Wu YL et al.. 2022. Propionate and butyrate attenuate macrophage pyroptosis and osteoclastogenesis induced by CoCrMo alloy particles.. Mil Med Res 9(1):46 PMID: 35996168
- 6. Rühl S et al.. 2018. ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation.. Science 362(6417):956-960 PMID: 30467171
- 7. Ding H et al.. 2025. Regulation of macrophage pyroptosis by SIRT1 during Pseudomonas aeruginosa-induced pneumonia.. Mol Immunol 185:92-104 PMID: 40714269
- 8. Li R et al.. 2025. Ameliorating macrophage pyroptosis via ANXA1/NLRP3/Caspase-1/GSDMD pathway: Ac2-26/OGP-loaded intelligent hydrogel enhances bone healing in diabetic periodontitis.. Biofabrication 17(2) PMID: 39773706
